Tag:
Menveo
Latest Headlines
Latest Headlines
Novartis gets Menveo vaccine approval
The FDA has approved Novartis' Menveo vaccine for use in 11-55 year olds to help protect against meningitis and sepsis caused by four common vaccine-preventable serogroups. That approval could help
Novartis delayed on Menveo app
The FDA has asked Novartis for more information on its meningitis vaccine Menveo, which is likely to push back any approval date to late this year or early in 2010. And the manufacturer was quick to
FDA wants more info on Novartis' Menveo vax
The FDA has asked Novartis for more information on its meningitis vaccine Menveo, which is likely to push back any approval date to late this year or early in 2010. And the manufacturer was quick to
Novartis plans trials for growing vaccines pipeline
Novartis is taking the wraps off its vaccine pipeline, highlighting plans for new trials as it talks up a lineup of vaccine candidates. Researchers for the company detailed plans that include a
Novartis reports strong meningitis vaccine response
In a head-to-head trial, researchers for Novartis say that the experimental meningitis vaccine Menveo produced a more potent immune response than the standard therapy in use. And other data has
